scholarly article | Q13442814 |
P50 | author | Hae-Sim Park | Q12597311 |
Yoo Seob Shin | Q57325316 | ||
Dong-Ho Nahm | Q84969330 | ||
Ji Ho Lee | Q88236931 | ||
Su Chin Kim | Q88236933 | ||
Hyunna Choi | Q88236935 | ||
Chang Gyu Jung | Q88236937 | ||
Ga-Young Ban | Q42428944 | ||
Young-Min Ye | Q42428945 | ||
P2093 | author name string | Yoo Seob Shin | |
Ji Ho Lee | |||
Young Min Ye | |||
Dong Ho Nahm | |||
Chang Gyu Jung | |||
Ga Young Ban | |||
Su Chin Kim | |||
Hyunna Choi | |||
P2860 | cites work | Injection allergen immunotherapy for asthma | Q24236566 |
Allergen Immunotherapy: Past, Present, and Future | Q26765974 | ||
Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System | Q34097796 | ||
Adult patients may outgrow their asthma: a 25-year follow-up study. | Q50961863 | ||
Subcutaneous immunotherapy in Northern Israel: efficacy and safety. | Q51263059 | ||
Advantages and disadvantages of accelerated immunotherapy schedules | Q81625091 | ||
Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis | Q83386200 | ||
Serum-specific IgE and allergen immunotherapy in allergic children | Q86955874 | ||
The use of single versus multiple antigens in specific allergen immunotherapy for allergic rhinitis: review of the evidence | Q86991980 | ||
Serum specific IgE: a biomarker of response to allergen immunotherapy | Q95589693 | ||
Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis. | Q35211932 | ||
Remission of asthma in the middle aged and elderly: report from the Obstructive Lung Disease in Northern Sweden study | Q35533173 | ||
Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report | Q38090066 | ||
An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. | Q38153965 | ||
The use of single versus multiple antigens in specific allergen immunotherapy for allergic rhinitis: review of the evidence | Q38169884 | ||
Immunotherapy: what lies beyond | Q38192150 | ||
Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens | Q38192151 | ||
Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective? | Q38194290 | ||
Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy | Q38244667 | ||
International consensus on allergy immunotherapy. | Q38544969 | ||
Assessing the safety of subcutaneous immunotherapy dose adjustments | Q39819994 | ||
Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey | Q41096295 | ||
Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010. | Q45376263 | ||
Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy. | Q48030345 | ||
Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy | Q48713439 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P921 | main subject | immunotherapy | Q1427096 |
allergic asthma | Q12301086 | ||
P304 | page(s) | 1124-1130 | |
P577 | publication date | 2017-07-01 | |
P1433 | published in | Journal of Korean Medical Science | Q24039955 |
P1476 | title | Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response Predictors | |
P478 | volume | 32 |
Search more.